This study evaluated the impact of specially trained community pharmacists on the health of patients with asthma. Researchers compared the health outcomes of two groups: those who received educational and monitoring services from specially trained pharmacists and those who received services from traditional pharmacists. Researchers followed 350 patients with asthma for at least one year and examined their health outcomes using patient self-reports, pharmacist reports, and government databases. This was a randomized, controlled trial in which community pharmacists monitored and managed the drug therapy of patients with asthma. Results were expected at the end of 2001.
This project was supported by the Health Transition Fund, which was created in 1997 to provide support for evidence-based decision-making in health care reform by supporting pilot and evaluation projects which test innovative approaches to health care delivery. The views expressed herein do no necessarily represent the official policy of federal, provincial, or territorial governments.